can you switch to semaglutide from tirzepatide vs. for Weight Loss What to Expect When Switching

Clinical studies have confirmed that hyperhomocysteinemia is not only an independent risk factor for the development of cardiovascular and cerebrovascular diseases, such as atherosclerosis, acute myocardial infarction, stroke, coronary artery lesions, and peripheral vascular disease, but also increases the risk of neurodegenerative disorders and tumors, and impairs the efficacy of antifolate drugs

There are studies that show that supplementation with L-Carnitine can increase the patients tolerable amount of exercise and make the symptoms of heart failure or coronary artery disease less pronounced

Frequently Asked Questions Can semaglutide (Wegovy) cause irregular periods

WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight

Wegovy supports average weight loss of 10-15%, which is well into the range associated with liver improvement